FDA — authorised 31 December 1987
- Application: NDA019594
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: ACTIGALL
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Actigall on 31 December 1987
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 31 December 1987; FDA authorised it on 31 December 1987; FDA authorised it on 14 March 2000.
TEVA BRANDED PHARM holds the US marketing authorisation.